Legato Capital Management LLC
Position in ETON — Eton Pharmaceuticals, Inc.
CIK 1442641
San Francisco, CA
Position in ETON
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$417,060
New position
Shares Held
11,521
first reported quarter
Ownership
0.040%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2026
1 quarter on record
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Legato Capital Management LLC holds $15,423,810 across 11 Drug Manufacturers - Specialty & Generic names. ETON ranks #10 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
87,297 | $5,582,643 | |
| 2 | LQDA |
Liquidia Corp
|
25,352 | $2,021,314 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
241,341 | $1,911,420 | |
| 4 | SIGA |
Siga Technologies Inc
|
512,039 | $1,863,821 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
22,000 | $902,660 | |
| 6 | PCRX |
Pacira BioSciences, Inc.
|
30,668 | $778,047 | |
| 7 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
34,135 | $688,844 | |
| 8 | SUPN |
Supernus Pharmaceuticals, Inc.
|
11,482 | $534,027 |
All Filings in ETON
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $417,060 | 11,521 | Shares | Other | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||